Search

Search Constraints

You searched for: Author/Creator Kaneko, Go

Search Results

1. Case Study: A Japanese patient with metastatic renal cell carcinoma who achieved long‐term treatment‐free survival with pembrolizumab and axitinib in the KEYNOTE‐426 phase III trial of pembrolizumab and axitinib versus sunitinib. Issue 3 (18th February 2022)

6. Predictive factors for the effectiveness of novel androgen receptor axis‐targeted agents in patients with metastatic prostate cancer. (7th September 2022)

7. Prognosis of patients with prostate cancer and bone metastasis from the Japanese Prostatic Cancer Registry of Standard Hormonal and Chemotherapy Using Bone Scan Index cohort study. (19th June 2021)

8. Progressive metastatic pheochromocytoma induced by multiple endocrine neoplasia type 2A with a lethal outcome. Issue 6 (6th September 2022)

9. Role of bone scan index in the prognosis and effects of therapy on prostate cancer with bone metastasis: Study design and rationale for the multicenter Prostatic Cancer Registry of Standard Hormonal and Chemotherapy Using Bone Scan Index (PROSTAT‐BSI) study. (6th April 2018)